ILA Mr Crudus Flashcards
What is Haemostasis?
Haemostasis describes the process the body undergoes to counteract a haemorrhage.
What is coagulation?
Coagulation is the process of forming a stable platelet plug at a site of haemorrhage to stop blood loss.
List the cells, factors, enzymes, and pathways involved in haemostasis.
- platelets - form the platelet plug and release ADP & Thromboxane A2.
- Von Willebrand Factor - binds to exposed collagen allowing platelets to initiate the plug.
- Factors I-XII (no factor VI) - form steps of the intrinsic and extrinsic cascade pathway.
- Vitamin K - required to synthesise many of the above factors.
- Thromboplastin - factor III, begins the extrinsic pathway.
- Thrombin - converts fibrinogen to fibrin, activates factor XIII to stablise fibrin meshwork, enhances platelet aggregation.
- Prostacyclin & nitric oxide - prevent the plug from growing past the limits of thesite of injury.
- Thromboxane A2 & ADP - activates & recruits passing platelets for the plug.
What are the platelets and how are they involved in clotting / haemostasis?
- Platelets are cell fragments that arise from megakaryocytes, and have many roles in haemostasis.
- Attach to vWF that is bound to exposed collagen in the site of injury, intiating a platelet plug.
- release ADP & thromboxane A2, which activate other passing platelets.
- Activated platelets have contractile filaments in their processes, allowing them to pull the edges of the wound site together.
What is thrombin and how is it involved in clotting / haemostasis?
- thrombin is an enzyme (protease), exists in the plasma as its inactive precursor prothrombin.
Roles: - Stimulates / catalyses conversion from fibrinogen (large soluble plasma protein) to fibrin (insoluble protein, loose network).
- activates factor XIII, which stabilises the fibrin network.
- Through positive feedback, enhances its won formation from prothrombin.
- enhances platelet aggregation.
What is thromboxane and how is it involved in clotting / haemostasis?
Roles:
1. Role in the formation of the platelet plug: TXA2 stimulates nearby platelets to become activated -> they change shape from disc-shaped and smooth to irregular with spiky processes/pseudopods -> helps them adhere to collagen and other platelets
2. Induce platelet degranulation -> release more ADP -> promotes platelet aggregation and further TXA2 formation.
3. TXA2 is also a vasoconstrictor, plays a role in the vascular spasm (first step in haemostasis). Vascular spasm slows blood flow and minimises blood loss.
What is prostaglandin and how is it involved in clotting / haemostasis?
Prostaglandin are hormone-like compounds
- Can activate (thromboxane A2) or inhibit platelet buildup (prostacyclin) for blood clot formation
- Cause vasoconstriction (thromboxane A2) or vasodilation (prostacyclin)
What is thromboxane A2?
Thromboxane A2
- Released by activated platelets
- Promotes platelet aggregation and further enhances it indirectly by triggering the release of more ADP from the platelet granules (Sherwood, 2015)
What is Fibrin and how is it involved in clotting process?
Fibrin is a fibrous protein that is converted from soluble fibrinogen to its insoluble fibrin to form a clot. Fibrinogen itself is responsible for the aggregation of platelets to form an initial plug at the site of injury, and once converted to the more insoluble form fibrin, it promotes adhesion and increases the stability of the clot.
Use a flow chart to display the clotting process.
What is the role of liver in haemostasis?
- Production of clotting and anticoagulation factors
- liver synthesises essential coagulation factors: I, II, V, VII, IX, X, XI, XII, and XIII.
- produces anticoagulants, including protein C, protein S, and antithrombin, which regulate the clotting cascade.
- activation of several factors (e.g., protein C&S) depends on liver-supplied Vitamin K. - Fibrinolysis
- liver produces plasminogen, converted to plasmin, which degrades fibrin clots during fibrinolysis. - Clearance of coagulation factors
- impaired liver function increases the risk of bleeding or thrombosis due to ineffective clearance and regulation of clotting factors.
What is the role of bone marrow in haemostasis?
- Haematopoiesis - bone marrow houses hematopoietic stem cells (HSCs), which differentiate into all blood cell types, including platelets crucial for haemostasis.
- Thrombopoiesis (platelet production) 0 bone marrow produces megakaryocytes, which give rise to platelets. -> primary haemostasis by forming a weak platelet plug.
- Primary haemostasis mechanism:
a). platelet adhesion - platelets aggregate at the injury site via interactions with von Willebrand factor (vWF) and exposed collagen, forming a plug.
b). platelet activation - activated paltelets release factors (e.g., ADP), changing shape to increase surface area and adhesion, leading to the formation of the parimy paltelet plug.
What are the causes of prolonged bleeding?
- blood disorders: haemophilia (deficiency in clotting factors), von Willebrand disease (enhance loss of factor VII -> limited activation of thrombin).
- medication: blood thinners: Warfarin (inhibitng vitK clotting factors), Heparin (natural occuring glycosaminoglycan -> enhances activity of antithrombin III which main target is thrombin -> inhibits conversion of fibrinogen to fibrin and paltelet aggregation), Aspirin (inhibits COX-1 in platelets -> responsible for thromboxane A2 production which participate in paltelet aggregation….)
- Liver disease
- Vitamin deficiency
- Trauma to blood vessels or organs
- cancers
How does intteruption to clotting cascade result in prolonged bleeding? (give 2 examples)
- Hemophilia: Genetic disorder where certain clotting factors (Factor VIII in Hemophilia A, Factor IX in Hemophilia B) are absent or deficient. Without these factors, the normal sequence of chemical reactions in the clotting cascade cannot continue, hence prolonged bleeding occurs even from minor injuries.
- Vitamin K Deficiency: Vitamin K is needed for the synthesis of clotting Factors II, VII, IX, and X. Deficiency in Vitamin K therefore interrupts the sequence of reactions in the clotting cascade. A vitamin K deficiency can occur due to inadequate dietary intake, certain medications (such as some antibiotics that affect Vitamin K metabolism), or malabsorption disorders.
Discuss the effect of Aspirin on Haemostasis.
Aspirin acts as an anticoagulant by irreversibly inhibiting the enzyme cyclo-oxygenase-1 (COX-1), which blocks the synthesis of prostaglandins. Prostaglandins are essential for platelet activation, as they make platelets sticky and trigger thrombin release, necessary for converting fibrinogen to fibrin. By inhibiting COX-1, aspirin reduces the production of thromboxane A2, a compound that promotes platelet activation and aggregation. Since platelets cannot regenerate COX-1, this effect lasts for their lifespan (about 8 days), leading to impaired platelet function, slower clot formation, and prolonged bleeding time.